Skip to main content

Table 1 Leukemic blast percentages in clinical bone marrow samples of the E/R-positive patients during induction therapy determined by flow cytometry

From: Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities

Sample ID

Leukemic blast percentage at diagnosis

Leukemic blast percentage at day 15

Leukemic blast percentage at day 29

ALL1

94

10

0.3

ALL3

95

74

0.16

ALL8

93

0.93

0.02

ALL9

79

0.17

0.01

ALL10

65

10

0.08

ALL12

90

59

0.2

ALL7

27

0

0

ALL13

80

0.04

0